Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.
about
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer inductionMonte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validationCancer risks attributable to low doses of ionizing radiation: assessing what we really knowSecond malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisExternal beam radiotherapy for localized prostate cancerSecond malignant neoplasms and cardiovascular disease following radiotherapy.Is there a role for IGF-1 in the development of second primary cancers?Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.Calculating integral dose using data exported from a commercial record and verify system.Melatonin Ameliorates The Production of COX-2, iNOS, and The Formation of 8-OHdG in Non-Targeted Lung Tissue after Pelvic Irradiation.Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma.A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.Solid tumor risks after high doses of ionizing radiationManagement of complications of prostate cancer treatment.Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancerGamma irradiation does not induce detectable changes in DNA methylation directly following exposure of human cells.Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.Minimizing second cancer risk following radiotherapy: current perspectives.Second primary cancers after radiation for prostate cancer: a review of data from planning studiesThe mechanisms of radiation-induced bystander effectProportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registriesImpact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.Assessment of contralateral mammary gland dose in the treatment of breast cancer using accelerated hypofractionated radiotherapy.Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer.Second malignancies among elderly survivors of cancer.Laparoscopic radical cystectomy.Radiotherapy and risks of tumor regrowth or inducing second cancer.Induction of Non-Targeted Stress Responses in Mammary Tissues by Heavy IonsRisk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis.Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantomMutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy.Risk of second cancers after radiotherapy for cervical cancer.Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy
P2860
Q24567501-10C75938-B5F1-412A-B396-F67446E19872Q24602734-2A8CEEDB-F79E-4D87-B5B5-CE12C6F2EB1FQ24631543-03D55FF2-0A8B-422D-B532-793D42668153Q26764960-71FAEFD1-A2FD-4DAE-B06E-9D647664E6A5Q26853068-C7247BE0-E64F-4CDF-807D-E345080469B1Q26864522-6059F266-2FF4-45E0-98C9-B84A8FAD5EF4Q28069262-0702595A-869A-40A5-B3C1-80E8CBC6007CQ30368547-E5076235-C755-413B-8FD2-C72DE01B8427Q30541361-D7B625B0-D1FF-49D8-8BC0-3D60CBDE15F2Q30591596-E02F6D34-D471-4432-8DDD-5AD51F74B084Q30746543-91594BE1-9BF6-4AE6-A63A-11DE870C5403Q30930901-4D25F2A0-0FB2-4116-9CC7-3861680C1281Q33625832-5C01E9A4-497B-4553-8CB9-457C07ECD0BBQ33646315-C47EEDA4-0464-4A0E-AD56-0B67970FF17EQ33820341-46E2FE53-1BD0-44A8-8075-59F97D66A83CQ33838842-6A2CD73E-595A-4D23-952F-01EFFC97E023Q33941735-32214AE7-E2F5-40B4-A0F4-D0089B315E3EQ33978360-FA302471-132C-40AF-AB3F-C62F79006903Q33998022-7470DEB0-BC5B-4D66-9131-DF9009810869Q34425083-BF4A8FD1-FB13-4EA8-B86C-A3A6D2DF812DQ34659767-81DAB2C4-E583-4EA4-B38E-A7F770D944A5Q34757180-8CB084BE-D30E-4F30-836D-1B234EE6A35DQ34802863-1FEB4C82-4038-4713-B05A-4D583606E611Q34900530-3D158056-DE7B-4CE6-88F4-F1512747BFC2Q34914474-75113233-F29D-4208-ADBB-900F7F80B341Q34973673-A0208AF0-3D66-414A-BC24-C5607A402637Q35356286-DFB298E7-FD3C-41CE-AC74-B5DE0D12604BQ35577274-EA238BF7-3834-4FDB-9BA0-5002CA204591Q35599802-A29E0800-29A4-4BB4-8FFA-4B7728C585D5Q35643013-0D28416B-3421-4B51-AAB0-D1A26E5415B6Q35672610-C849EDC4-7D85-4433-8F3D-F92F089564DCQ35758937-8BBCC5CC-7F7E-4CF9-99A1-33E95E202587Q35793117-B714300E-DBFC-40FA-B640-050BB5ACAA9BQ35808214-F5C96124-4B3F-4882-A6A5-F4306259FCE6Q35818426-CC4CCEA7-28FD-4FD1-8992-3BD7DA87FCABQ35821065-10DA4310-96E9-442E-9382-C9E0A2BF5E3FQ36038149-6968ABAA-06D0-4AAD-8EF0-974A654D2690Q36057129-D18BA196-1662-476C-A47D-B3D3B0C53A5BQ36352077-CECB4D4C-1E23-419F-ABAA-FD35B9522D11Q36440585-676378BF-07D6-4CE9-89C8-30687C91E2A5
P2860
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Second malignancies in prostat ...... therapy compared with surgery.
@ast
Second malignancies in prostat ...... therapy compared with surgery.
@en
type
label
Second malignancies in prostat ...... therapy compared with surgery.
@ast
Second malignancies in prostat ...... therapy compared with surgery.
@en
prefLabel
Second malignancies in prostat ...... therapy compared with surgery.
@ast
Second malignancies in prostat ...... therapy compared with surgery.
@en
P2093
P2860
P1433
P1476
Second malignancies in prostat ...... therapy compared with surgery.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V
P407
P577
2000-01-01T00:00:00Z